SCHEDULE 13G: Neurocords LLC and Ariel Malik Disclose Significant 18.84% Passive Stake in Orgenesis, Inc.

Neurocords LLC and Ariel Malik have disclosed a significant passive ownership stake of 18.84% in Orgenesis, Inc. through a Schedule 13G filing.

Summary

• Neurocords LLC and Ariel Malik have jointly filed a Schedule 13G with the SEC, reporting their beneficial ownership in Orgenesis, Inc.
• The reporting persons collectively own 1,200,000 shares of Orgenesis, Inc. common stock.
• This ownership represents 18.84% of the total 6,369,248 outstanding shares of Orgenesis, Inc. common stock.
• Ariel Malik, a citizen of Israel, is the manager and sole member of Neurocords LLC, a Delaware limited liability company.
• Ariel Malik holds sole voting and dispositive power over all 1,200,000 shares held by Neurocords LLC.
• The filing indicates that the securities were acquired and are held for passive investment purposes, not for changing or influencing the control of Orgenesis, Inc.

Sentiment

Score: 7

Explanation: The filing indicates a significant passive ownership stake by Neurocords LLC and Ariel Malik, which can be viewed as a positive signal of investor confidence in Orgenesis, Inc.

Positives

• A significant investor, Neurocords LLC and Ariel Malik, has taken an 18.84% stake in Orgenesis, Inc., which can signal increased investor confidence in the company's prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may view the significant stake taken by Neurocords LLC and Ariel Malik as a positive indicator of confidence in the company's future.

Key Dates

Keywords

Orgenesis Inc., Neurocords LLC, Ariel Malik, Schedule 13G, Beneficial Ownership, Common Stock, Passive Investment